NEW YORK (GenomeWeb) – Trovagene said today it has closed a public offering of its common stock that brought in approximately $40.3 million in gross proceeds.

The company sold 4.6 million shares, including 600,000 shares issued when the offering's underwriters exercised their full overallotment option. The offering price was $8.75 per share, Trovagene said. The firm plans to use net proceeds for research and development, working capital, and to support other general corporate activities.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.